Highly absorbable coenzyme Q10 composition and method of producing same
The present invention provides an essentially crystal-free, highly bioavailable and absorbable coenzyme Q10 (CoQ10) composition including CoQ10, a solvent, and a carrier oil for supplementing nutrition and for use as an antioxidant. The present invention further provides method of increasing the absorption and bioavailability levels of coenzyme Q10 in the blood plasma and a method of producing a highly absorbable CoQ10 composition.
1. A crystal-free coenzyme Q10 composition comprising: non-crystalline coenzyme Q10 present in an amount of 5.3% by weight to about 12% by weight based on the total weight of the composition; a solvent selected from the group consisting of conjugated linoleic acid, ethyl ester marine lipids, citrus oils, and combinations thereof; and a carrier oil.
2. The composition in accordance with claim 1 wherein about 50 mg coenzyme Q10 is encapsulated in a 700-900 mg capacity softgel.
3. The composition in accordance with claim 1 further comprising vegetable monoglycerides.
4. The composition in accordance with claim 3 further comprising vegetable diglycerides.
5. The composition in accordance with claim 1 wherein the solvent comprises conjugated linoleic acid.
6. The composition in accordance with claim 1 wherein the solvent comprises ethyl ester marine lipids.
7. The composition in accordance with claim 1 wherein the solvent comprises citrus oils.
8. The composition in accordance with claim 1 wherein the carrier oil comprises flax seed oil.
9. The composition in accordance with claim 1 wherein the carrier oil is selected from the group consisting of: soy lipids, borage lipids and marine lipids.
10. The composition in accordance with claim 1 wherein the composition is encapsulated in a 14 oblong softgel capsule.
11. A method of increasing coenzyme Q10 levels in blood plasma comprising administering an effective amount of the composition of claim 1 wherein the plasma coenzyme Q10 level is increased significantly from a basal level.
12. The method in accordance with claim 11 wherein the coenzyme Q10 absorption level in the blood plasma is 7-10% of a 100 mg dose of the composition of claim 1 in 6-8 hours.
13. The method in accordance with claim 11 wherein the coenzyme Q10 bioavailability level in the blood plasma is at least 4 μg/mL.
14. A crystal-free coenzyme Q10 composition comprising:
an amount of 5.3% by weight to about 12% by weight non-crystalline coenzyme Q10;
53-63% by weight solvent selected from the group consisting of conjugated linoleic acid, ethyl ester marine lipids, citrus oils, and combinations thereof;
1-20% by weight fatty acids; and
24-34% by weight carrier oil.
15. The crystal-free coenzyme Q10 composition of claim 14 wherein:
the fatty acids are selected from the group consisting of capric and caprylic glycerides, vegetable monoglycerides, vegetable diglycerides and combinations thereof; and
the carrier oil is selected from the group consisting of flax seed oil, soy lipids, borage lipids, marine lipids and combinations thereof.
16. A crystal-free coenzyme Q10 composition comprising:
50 mg non-crystalline coenzyme Q10;
400 mg conjugated linoleic acid;
40 mg vegetable monoglycerides; and
200 mg flax seed oil.